{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:36:05Z","timestamp":1772555765197,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10833-6","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T09:40:47Z","timestamp":1743414047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Outcomes of non-hospitalized patients with COVID-19 versus seasonal influenza during the fall-winter 2022\u20132023 period"],"prefix":"10.1186","volume":"25","author":[{"given":"Wan-Hsuan","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Wen","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jheng-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hsiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"10833_CR1","unstructured":"World Health Organization. https:\/\/covid19.who.int\/ Accessed on June 12, 2023."},{"issue":"4","key":"10833_CR2","doi-asserted-by":"crossref","first-page":"105946","DOI":"10.1016\/j.ijantimicag.2020.105946","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai CC, Wang CY, Wang YH, et al. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020;55(4):105946.","journal-title":"Int J Antimicrob Agents"},{"key":"10833_CR3","unstructured":"Statement on the fifteenth meeting of the IHR. (2005) Emergency Committee on the COVID-19 pandemic [press release]. 5 May 2023."},{"key":"10833_CR4","unstructured":"End of the Federal COVID-19. Public Health Emergency (PHE) Declaration [press release]. 5 May 2023."},{"key":"10833_CR5","unstructured":"Ministry of Health LaW. Japan. Response to COVID 19 (Novel Coronavirus) after the classification change."},{"key":"10833_CR6","unstructured":"Statement from Emer Cooke on the end. of the COVID-19 public health emergency [press release]. 8 May 2023."},{"issue":"19","key":"10833_CR7","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/jama.2023.5348","volume":"329","author":"Y Xie","year":"2023","unstructured":"Xie Y, Choi T, Al-Aly Z. Risk of death in patients hospitalized for COVID-19 vs seasonal influenza in Fall-Winter 2022\u20132023. JAMA. 2023;329(19):1697\u20139.","journal-title":"JAMA"},{"issue":"1","key":"10833_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmii.2022.10.003","volume":"56","author":"CC Lai","year":"2023","unstructured":"Lai CC, Hsu CK, Yen MY, et al. Long COVID: an inevitable sequela of SARS-CoV-2 infection. J Microbiol Immunol Infect. 2023;56(1):1\u20139.","journal-title":"J Microbiol Immunol Infect"},{"key":"10833_CR9","first-page":"1","volume":"2","author":"U Topaloglu","year":"2018","unstructured":"Topaloglu U, Palchuk MB. Using a federated network of Real-World data to optimize clinical trials operations. JCO Clin Cancer Inf. 2018;2:1\u201310.","journal-title":"JCO Clin Cancer Inf"},{"issue":"2","key":"10833_CR10","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, et al. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6(2):ooad035.","journal-title":"JAMIA Open"},{"key":"10833_CR11","unstructured":"TriNetX. https:\/\/trinetx.com. Accessed June 25, 2023."},{"key":"10833_CR12","doi-asserted-by":"crossref","unstructured":"Hsu WH, Shiau BW, Tsai YW et al. The effect of molnupiravir on post-acute outcome of COVID-19 survivors. J Infect 2023.","DOI":"10.1016\/j.jinf.2023.03.016"},{"issue":"4","key":"10833_CR13","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.jinf.2023.02.007","volume":"86","author":"WH Hsu","year":"2023","unstructured":"Hsu WH, Tsai YW, Wu JY, Liu TH, Lai CC. Post-acute hospitalization and mortality of nirmatrelvir plus Ritonavir for COVID-19 survivors. J Infect. 2023;86(4):e107\u201310.","journal-title":"J Infect"},{"issue":"4","key":"10833_CR14","doi-asserted-by":"crossref","first-page":"e28750","DOI":"10.1002\/jmv.28750","volume":"95","author":"MH Chuang","year":"2023","unstructured":"Chuang MH, Wu JY, Liu TH, et al. Efficacy of nirmatrelvir and Ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection. J Med Virol. 2023;95(4):e28750.","journal-title":"J Med Virol"},{"issue":"5","key":"10833_CR15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jmii.2021.05.011","volume":"54","author":"CC Lai","year":"2021","unstructured":"Lai CC, Chao CM, Hsueh PR. Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. J Microbiol Immunol Infect. 2021;54(5):767\u201375.","journal-title":"J Microbiol Immunol Infect"},{"issue":"3","key":"10833_CR16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jinf.2023.01.006","volume":"86","author":"YW Tsai","year":"2023","unstructured":"Tsai YW, Tsai CF, Wu JY, et al. The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: A retrospective cohort study from the TriNetX network. J Infect. 2023;86(3):256\u2013308.","journal-title":"J Infect"},{"issue":"3","key":"10833_CR17","first-page":"256","volume":"86","author":"TH Liu","year":"2023","unstructured":"Liu TH, Wu JY, Huang PY, Tsai YW, Lai CC. The effect of nirmatrelvir plus Ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients. J Infect. 2023;86(3):256\u2013308.","journal-title":"J Infect"},{"issue":"15","key":"10833_CR18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","volume":"314","author":"JS Haukoos","year":"2015","unstructured":"Haukoos JS, Lewis RJ. The propensity score. JAMA. 2015;314(15):1637\u20138.","journal-title":"JAMA"},{"key":"10833_CR19","unstructured":"Bhimraj A, Morgan RL, Shumaker AH et al. Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis 2022."},{"issue":"6","key":"10833_CR20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","volume":"68","author":"TM Uyeki","year":"2019","unstructured":"Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis. 2019;68(6):e1\u201347.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10833_CR21","doi-asserted-by":"crossref","first-page":"e0292017","DOI":"10.1371\/journal.pone.0292017","volume":"18","author":"J Dickow","year":"2023","unstructured":"Dickow J, Gunawardene MA, Willems S, et al. Higher in-hospital mortality in SARS-CoV-2 Omicron variant infection compared to influenza infection-Insights from the CORONA Germany study. PLoS ONE. 2023;18(9):e0292017.","journal-title":"PLoS ONE"},{"key":"10833_CR22","doi-asserted-by":"crossref","unstructured":"Kopel H, Bogdanov A, Winer-Jones JP et al. Comparison of COVID-19 and Influenza-Related outcomes in the united States during Fall-Winter 2022\u20132023: A Cross-Sectional retrospective study. Diseases 2024;12(1).","DOI":"10.3390\/diseases12010016"},{"key":"10833_CR23","unstructured":"National Institutes of Health. Information on COVID-19 treatment, prevention and research. COVID-19 Treatment Guidelines. https:\/\/www.covid19treatmentguidelines.nih.gov\/ Accessed April 15, 2023."},{"issue":"6","key":"10833_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.2021.11330","volume":"326","author":"M Shankar-Hari","year":"2021","unstructured":"Shankar-Hari M, Vale CL, Godolphin PJ, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: A Meta-analysis. JAMA. 2021;326(6):499\u2013518.","journal-title":"JAMA"},{"issue":"13","key":"10833_CR25","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"Sterne JAC, Murthy S, Diaz JV, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A Meta-analysis. JAMA. 2020;324(13):1330\u201341.","journal-title":"JAMA"},{"key":"10833_CR26","doi-asserted-by":"crossref","unstructured":"Chen JY, Wei SK, Lai CC, Weng TS, Wang HH. A Meta-Analysis comparing the efficacy and safety of peramivir with other neuraminidase inhibitors for influenza treatment. Med (Kaunas) 2020;56(2).","DOI":"10.3390\/medicina56020063"},{"issue":"6","key":"10833_CR27","doi-asserted-by":"crossref","first-page":"102629","DOI":"10.1016\/j.aprim.2023.102629","volume":"55","author":"F L\u00f3pez-Medrano","year":"2023","unstructured":"L\u00f3pez-Medrano F, Alfayate S, Carratal\u00e0 J, et al. Executive summary - Diagnosis, treatment and prophylaxis of influenza virus infection - Consensus statement of the Spanish society of infectious diseases and clinical microbiology (SEIMC), the Spanish society of pediatric infectious diseases (SEIP), the Spanish association of vaccinology (AEV), the Spanish society of family and community medicine (SEMFYC) and the Spanish society of preventive medicine, public health and health management (SEMPSPGS). Aten Primaria. 2023;55(6):102629.","journal-title":"Aten Primaria"},{"issue":"1","key":"10833_CR28","doi-asserted-by":"crossref","first-page":"e000421","DOI":"10.1136\/bmjmed-2022-000421","volume":"2","author":"V Lo Re","year":"2023","unstructured":"Lo Re V 3rd, Dutcher SK, Connolly JG, et al. Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort study. BMJ Med. 2023;2(1):e000421.","journal-title":"BMJ Med"},{"issue":"4","key":"10833_CR29","doi-asserted-by":"crossref","first-page":"e1004194","DOI":"10.1371\/journal.pmed.1004194","volume":"20","author":"KW Fung","year":"2023","unstructured":"Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: an observational cohort study of over 2 million adults in the US. PLoS Med. 2023;20(4):e1004194.","journal-title":"PLoS Med"},{"issue":"4","key":"10833_CR30","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciad660","volume":"78","author":"P Hedberg","year":"2024","unstructured":"Hedberg P, Karlsson Valik J, Abdel-Halim L, Alfv\u00e9n T, Naucl\u00e9r P. Outcomes of SARS-CoV-2 Omicron variant infections compared with seasonal influenza and respiratory syncytial virus infections in adults attending the emergency department: A multicenter cohort study. Clin Infect Dis. 2024;78(4):900\u20137.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10833-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10833-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10833-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T09:41:27Z","timestamp":1743414087000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10833-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10833"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10833-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for written informed consent was waived owing to the utilization of deidentified aggregate data. The study adhered to the Declaration of Helsinki and was approved by the Institutional Review Board of Chi Mei Medical Center (approval number 11202-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declared that there was no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"442"}}